Daniel W Sirkis1, Luke W Bonham1, Celeste M Karch2, Jennifer S Yokoyama1. 1. Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, California. 2. Hope Center for Neurological Disorders, Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri, USA.
Abstract
PURPOSE OF REVIEW: Over the last year, research into the immunological and inflammatory signatures of frontotemporal lobar degeneration (FTLD) has accelerated greatly. Herein, we highlight recently proposed roles of brain-resident microglia as well as peripheral myeloid cells in frontotemporal dementia (FTD)-spectrum disorders. RECENT FINDINGS: Recent unbiased genetic, transcriptomic, and proteomic surveys using human data confirm significantly altered immune-function genes as well as transcript and protein modules associated with inflammatory and immune function. Beyond human studies, novel animal models indicate important roles for both microglia and monocytes, and central involvement of genes such as Trem2, Apoe, and Tbk1. SUMMARY: The importance of neuroinflammatory activity in FTD pathophysiology is unambiguous, but whether this activity is primarily beneficial or detrimental remains unclear, with variable results reported for distinct disease paradigms. Going forward, it will be crucial to determine which types of microglial and peripheral myeloid responses are favorable, in response to which specific proteinopathies, and at which point in disease course.
PURPOSE OF REVIEW: Over the last year, research into the immunological and inflammatory signatures of frontotemporal lobar degeneration (FTLD) has accelerated greatly. Herein, we highlight recently proposed roles of brain-resident microglia as well as peripheral myeloid cells in frontotemporal dementia (FTD)-spectrum disorders. RECENT FINDINGS: Recent unbiased genetic, transcriptomic, and proteomic surveys using human data confirm significantly altered immune-function genes as well as transcript and protein modules associated with inflammatory and immune function. Beyond human studies, novel animal models indicate important roles for both microglia and monocytes, and central involvement of genes such as Trem2, Apoe, and Tbk1. SUMMARY: The importance of neuroinflammatory activity in FTD pathophysiology is unambiguous, but whether this activity is primarily beneficial or detrimental remains unclear, with variable results reported for distinct disease paradigms. Going forward, it will be crucial to determine which types of microglial and peripheral myeloid responses are favorable, in response to which specific proteinopathies, and at which point in disease course.
Authors: Harald Lund; Melanie Pieber; Roham Parsa; David Grommisch; Ewoud Ewing; Lara Kular; Jinming Han; Keying Zhu; Jik Nijssen; Eva Hedlund; Maria Needhamsen; Sabrina Ruhrmann; André Ortlieb Guerreiro-Cacais; Rasmus Berglund; Maria J Forteza; Daniel F J Ketelhuth; Oleg Butovsky; Maja Jagodic; Xing-Mei Zhang; Robert A Harris Journal: Nat Immunol Date: 2018-04-16 Impact factor: 25.606
Authors: Axel Freischmidt; Thomas Wieland; Benjamin Richter; Wolfgang Ruf; Veronique Schaeffer; Kathrin Müller; Nicolai Marroquin; Frida Nordin; Annemarie Hübers; Patrick Weydt; Susana Pinto; Rayomond Press; Stéphanie Millecamps; Nicolas Molko; Emilien Bernard; Claude Desnuelle; Marie-Hélène Soriani; Johannes Dorst; Elisabeth Graf; Ulrika Nordström; Marisa S Feiler; Stefan Putz; Tobias M Boeckers; Thomas Meyer; Andrea S Winkler; Juliane Winkelman; Mamede de Carvalho; Dietmar R Thal; Markus Otto; Thomas Brännström; Alexander E Volk; Petri Kursula; Karin M Danzer; Peter Lichtner; Ivan Dikic; Thomas Meitinger; Albert C Ludolph; Tim M Strom; Peter M Andersen; Jochen H Weishaupt Journal: Nat Neurosci Date: 2015-03-24 Impact factor: 24.884
Authors: Brad A Friedman; Karpagam Srinivasan; Gai Ayalon; William J Meilandt; Han Lin; Melanie A Huntley; Yi Cao; Seung-Hye Lee; Patrick C G Haddick; Hai Ngu; Zora Modrusan; Jessica L Larson; Joshua S Kaminker; Marcel P van der Brug; David V Hansen Journal: Cell Rep Date: 2018-01-16 Impact factor: 9.423
Authors: Yang Shi; Kaoru Yamada; Shane Antony Liddelow; Scott T Smith; Lingzhi Zhao; Wenjie Luo; Richard M Tsai; Salvatore Spina; Lea T Grinberg; Julio C Rojas; Gilbert Gallardo; Kairuo Wang; Joseph Roh; Grace Robinson; Mary Beth Finn; Hong Jiang; Patrick M Sullivan; Caroline Baufeld; Michael W Wood; Courtney Sutphen; Lena McCue; Chengjie Xiong; Jorge L Del-Aguila; John C Morris; Carlos Cruchaga; Anne M Fagan; Bruce L Miller; Adam L Boxer; William W Seeley; Oleg Butovsky; Ben A Barres; Steven M Paul; David M Holtzman Journal: Nature Date: 2017-09-20 Impact factor: 69.504
Authors: Yaming Wang; Marina Cella; Kaitlin Mallinson; Jason D Ulrich; Katherine L Young; Michelle L Robinette; Susan Gilfillan; Gokul M Krishnan; Shwetha Sudhakar; Bernd H Zinselmeyer; David M Holtzman; John R Cirrito; Marco Colonna Journal: Cell Date: 2015-02-26 Impact factor: 41.582
Authors: Rita Guerreiro; Aleksandra Wojtas; Jose Bras; Minerva Carrasquillo; Ekaterina Rogaeva; Elisa Majounie; Carlos Cruchaga; Celeste Sassi; John S K Kauwe; Steven Younkin; Lilinaz Hazrati; John Collinge; Jennifer Pocock; Tammaryn Lashley; Julie Williams; Jean-Charles Lambert; Philippe Amouyel; Alison Goate; Rosa Rademakers; Kevin Morgan; John Powell; Peter St George-Hyslop; Andrew Singleton; John Hardy Journal: N Engl J Med Date: 2012-11-14 Impact factor: 91.245
Authors: Cheryl E G Leyns; Jason D Ulrich; Mary B Finn; Floy R Stewart; Lauren J Koscal; Javier Remolina Serrano; Grace O Robinson; Elise Anderson; Marco Colonna; David M Holtzman Journal: Proc Natl Acad Sci U S A Date: 2017-10-09 Impact factor: 11.205